The Potential of Bio-Serum Particles for Women's Health

Advancing Women's Health Through Autologous Biologics

Bio Serum Particles™ (BSPs) are proprietary, biologically derived components developed by BSP Biologics and are being studied for their potential to support cellular signaling and microenvironmental conditions within gynecologic and reproductive tissues.

Research Context in Women's Health

BSPs are currently under investigation for their potential relevance in areas of women's health where tissue environment and cellular communication are important, including endometriosis, polycystic ovary syndrome (PCOS), age-related ovarian changes, and menopause-associated physiological shifts.

Preclinical and exploratory research is focused on understanding how BSPs may influence local biological signaling, tissue characteristics, and cellular interactions in reproductive and gynecologic settings.

BSPs are autologous biologic preparations processed under controlled conditions and intended for use within established regulatory frameworks governing human cellular and tissue-based products.

Clinical Applications in Women's Health

Pelvic Tissue Recovery

• May support tissue healing following gynecological procedures, childbirth, or surgical interventions.
• Could help restore normal physiological function through potential regenerative and anti-inflammatory properties.

Inflammatory Response Modulation

• May utilize immune-modulating extracellular vesicles to support tissue balance.
• Could help promote a more balanced pelvic microenvironment.
• May be beneficial in contexts involving chronic inflammation or immune dysregulation.

Endometrial Health and Receptivity

• May support angiogenesis, endometrial thickness, and gene expression associated with implantation.
• Could deliver immune-modulating extracellular vesicles that may promote tolerance at the maternal–embryo interface.
• May be considered in contexts such as thin endometrial lining, recurrent implantation challenges, or a history of uterine injury.

Ovarian Support and Activation

• May provide regenerative, antioxidative, and anti-apoptotic signaling to granulosa and stromal cells.
• Could support the follicular microenvironment, potentially contributing to oocyte quality and blastocyst development.
• May be relevant in contexts such as diminished ovarian reserve, ovarian aging, or oxidative stress.

Luteal Phase Stabilization

• May support vascular integrity and hormonal responsiveness of the endometrium.
• Could help maintain the implantation window following egg retrieval and embryo transfer.
• May be beneficial in contexts such as recurrent early pregnancy loss or luteal phase insufficiency.

Blastocyst Support

• May support blastocyst adhesion, migration, and invasion involved in endometrial embedding.
• Could deliver extracellular vesicles containing proteins and nucleic acids that may support cell–cell communication and trophoblast outgrowth.
• May be considered in contexts such as low implantation rates, recurrent pregnancy loss, or suboptimal embryo–uterine synchrony.

Safety, Compliance & Clinical Rigor

Because Bio-Serum Particles are autologous—derived exclusively from each patient's own biologic sample—there is no risk of immunogenicity or immune rejection. Each therapy is uniquely tailored to the individual patient, maximizing compatibility and minimizing adverse reactions.

BSP Biologics operates in alignment with FDA 21 CFR Part 1271 frameworks governing human cellular and tissue-based products (HCT/Ps). All processes are conducted within controlled environments and aligned with internal standard operating procedures and applicable regulatory frameworks. Our commitment to safety, traceability, and clinical validation ensures that Women's Health practitioners can confidently integrate BSP therapeutics into their patient care protocols.

Each BSP preparation undergoes defined quality control assessments prior to clinical use, with release criteria designed to support consistency, traceability, and controlled handling of patient-derived biologic material.